Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...
Novo Nordisk announced that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients.
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback